Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 246-186-9 | CAS number: 24347-58-8
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
![](https://echa.europa.eu/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/print_toxicological-information.png)
Eye irritation
Administrative data
- Endpoint:
- eye irritation: in vitro / ex vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 04 January 2019 - 31 January 2019
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 019
- Report date:
- 2019
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 492 (Reconstructed Human Cornea-like Epithelium (RhCE) Test Method for Identifying Chemicals Not Requiring Classification and Labelling for Eye Irritation or Serious Eye Damage)
- Version / remarks:
- 25th June 2018
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
Test material
- Reference substance name:
- (R,R)-(-)-butane-2,3-diol
- EC Number:
- 246-186-9
- EC Name:
- (R,R)-(-)-butane-2,3-diol
- Cas Number:
- 24347-58-8
- Molecular formula:
- C4H10O2
- IUPAC Name:
- (R,R)-(-)-butane-2,3-diol
- Reference substance name:
- (2R,3S)-butane-2,3-diol
- Cas Number:
- 5341-95-7
- Molecular formula:
- CH3CH(OH)CH(OH)CH3
- IUPAC Name:
- (2R,3S)-butane-2,3-diol
- Reference substance name:
- (2S,3S)-butane-2,3-diol
- Cas Number:
- 19132-06-0
- Molecular formula:
- C4H10O2
- IUPAC Name:
- (2S,3S)-butane-2,3-diol
- Test material form:
- liquid
- Details on test material:
- Identification: 2,3-butanediol ((2R,3R)-rich)
Batch: GSC180130-110
Serial No.: GSC181119B
Appearance: Colourless liquid
Expiry Date: 28 January 2020
Constituent 1
impurity 1
impurity 2
- Specific details on test material used for the study:
- SOURCE OF TEST MATERIAL
- Source and lot/batch No.of test material: GSC180130-110
- Serial No.: GSC181119B
- Expiration date of the lot/batch: 28 January 2020
STABILITY AND STORAGE CONDITIONS OF TEST MATERIAL
- Storage condition of test material: At room temperature
TREATMENT OF TEST MATERIAL PRIOR TO TESTING
- Treatment of test material prior to testing: Not applicable
Test animals / tissue source
- Species:
- human
- Details on test animals or tissues and environmental conditions:
- The EpiOcular™ tissue consists of normal, human-derived epidermal keratinocytes which have been cultured to form a stratified squamous epithelium similar to that found in the human cornea. It consists of highly organized basal cells which progressively flatten out as the apical surface of the tissue is approached, analogous to the normal in vivo corneal epithelium.
Test system
- Vehicle:
- unchanged (no vehicle)
- Controls:
- yes, concurrent positive control
- yes, concurrent negative control
- Amount / concentration applied:
- TEST MATERIAL
- Amount(s) applied (volume or weight with unit): 50 μL (83.3 μL/cm² according to guideline) - Duration of treatment / exposure:
- 30 min
- Duration of post- treatment incubation (in vitro):
- 120 min
- Number of animals or in vitro replicates:
- 2
- Details on study design:
- - RhCE tissue construct used, including batch number: EpiOcular™ kits, Lot No.: 27089 (MatTek Corporation, 82105, Bratislava, Slovakia)
- Doses of test chemical and control substances used: 50 µL undiluted test substance, positive (PC) and negative control (NC)
- Duration and temperature of exposure, post-exposure immersion and post-exposure incubation periods (where applicable): 30 min exposure at 37 ± 1.5°C, 120 min post-incubation in medium at 37 ± 1.5°C
- Number of tissue replicates used per test chemical and controls (positive control, negative control, NSMTT, NSCliving and NSCkilled, if applicable): 2
- Wavelength and band pass (if applicable) used for quantifying MTT formazan, and linearity range of measuring device (e.g. spectrophotometer): The absorbance at 570 nm (OD570) of each well was measured with a plate reader (Versamax® Molecular Devices, 85737 Ismaning, Germany, Software Softmax Pro Enterprise, version 4.7.1). No reference wavelength measurement was used.
- Description of the method used to quantify MTT formazan:
At the end of the post-treatment incubation, each insert was removed from the 6-well plate and gently blotted on absorbent material. The tissues were placed into the 24-well plate containing 0.3 mL of MTT solution. Once all the tissues were placed into the 24-well plate, the plate was incubated for 180 minutes at standard culture conditions.
Since the test item was colourless inserts were removed from the 24-well plate after 180 minutes; the bottom of the insert was blotted on absorbent material, and then transferred to a pre-labelled 24-well plate containing 2 mL isopropanol in each well so that isopropanol was flowing into the insert. The plates were sealed with parafilm and a standard plate sealer, and were stored about 18 h at 2-8 °C in the dark. To extract the MTT, the tissues were pierced and the plates were placed on an orbital plate shaker and shaken for 2.5 hours at room temperature. The corresponding negative, positive, and additional viable tissues (without MTT addition) were treated identically with piercing.
The extract solution was mixed and two 200 μL aliquots were transferred to the appropriate wells of a pre-labelled 96-well plate.
- Prediction model:
If the test item-treated tissue viability is > 60% relative to the negative control-treated tissue viability, the test item is labeled non-irritant (no Category according to UN GHS).
If the test item-treated tissue viability is ≤ 60% relative to negative control-treated tissue viability, the test item is labeled irritant (Category 2 or Category 1 according to UN GHS; no differentiation between the categories possible).
A single test composed of at least two tissue replicates should be sufficient for a test chemical, when the result is unequivocal. However, in cases of borderline results, such as non-concordant replicate measurements and/or mean percent tissue viability equal to 60±5%, a second test should be considered, as well as a third one in case of discordant results between the first two tests.
- Reference to historical positive and negative control results demonstrating suitable run acceptance criteria: yes
- Reference to historical data of the RhCE tissue construct: yes
- Demonstration of proficiency in performing the test method before routine use by testing of the proficiency chemicals: yes
- Acceptability of the Assay
1) The negative control mean OD is > 0.8 and < 2.5,
2) The mean relative viability of the positive control is below 50% of the negative control viability.
3) The difference of viability between the two relating tissues of a single test item is < 20% in the same run (for positive and negative control tissues and tissues of test items).
4) The positive and negative control data shall fall within the historical control data.
- Positive and negative control means and acceptance ranges based on historical data
PC and NC data fell within the historical control data.
- Acceptable variability between tissue replicates for test chemical, positive and negative controls
The difference of viability between the two relating tissues of a single item is < 20% (values between 0.45 p.p and 2.67 p.p) in the same run (for positive and negative control tissues and tissues of single test items).
Results and discussion
In vitro
Results
- Irritation parameter:
- other: % viability
- Run / experiment:
- 30 min exposure/180 min post-incubation
- Value:
- 85.31
- Negative controls validity:
- valid
- Remarks:
- 100%
- Positive controls validity:
- valid
- Remarks:
- 29.91%
- Remarks on result:
- no indication of irritation
- Other effects / acceptance of results:
- The viability value of the test item exposed tissues was 85.31% when compared to negative control and hence did not decrease below 60%.
Any other information on results incl. tables
Test Group |
Tissue No. |
Well 1 [OD570] |
Well 2 [OD570] |
Mean [OD570] (Well 1 and well 2) |
Mean [OD570] blank corr. (Well 1 and well 2) |
Mean [OD570] of T1 and T2 |
Tissue viabil.* [%] |
rel. viabil. of T1 and T2** |
Diff. of viabil. between T1 and T2 [p.p.] |
Blank |
|
0.035 |
0.035 |
0.035 |
|
||||
Negative Control |
1 |
2.481 |
2.438 |
2.459 |
2.424 |
2.457 |
100.0 |
98.7 |
2.67 |
2 |
2.559 |
2.491 |
2.525 |
2.490 |
101.3 |
||||
Positive Control |
1 |
0.796 |
0.768 |
0.782 |
0.747 |
0.735 |
29.91 |
30.4 |
0.98 |
2 |
0.763 |
0.753 |
0.758 |
0.723 |
29.4 |
||||
Test Item |
1 |
2.218 |
2.033 |
2.126 |
2.090 |
2.096 |
85.31 |
85.1 |
0.45 |
2 |
2.173 |
2.101 |
2.137 |
2.101 |
85.5 |
* Tissue viability = [100 × meanOD blank corrected of T1&T2test item / positve control / negative control]/[meanOD of T1&T2negative control]
** Relative Tissue viability = [100 × meanOD blank correctedtest item / positive control / negative control]/[meanOD of T1&T2negative control]
Applicant's summary and conclusion
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- In conclusion, it can be stated that in this study and under the experimental conditions reported, 2,3-butanediol ((2R,3R)-rich) does not need to be classified according UN GHS.
- Executive summary:
This in vitro study was performed to assess the eye irritation potential of 2,3-butanediol ((2R,3R)-rich) by means of the Human Cornea Model Test. The study was conducted according to OECD 492 (adopted 2018) and in compliance with GLP. Tissues of the human cornea model EpiOcular™ were treated with 50 μL of the test item, the positive and the negative control. The viability was measured after 30 min exposure and 2 hours post-incubation.
Since the viability value of the test item exposed tissues was 85.31% when compared to negative control and hence did not decrease below 60%, the test item is not considered to possess an eye irritating potential. This study results were considered acceptable, because treatment with the positive control induced a decrease in the mean tissue viability compared with the negative control to 29.91%. The study was considered reliable and adequate as part of the hazard assessment of eye irritation.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
![ECHA](/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/echa_logo.png)